chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: RSV
Symptoms: Atrial fibrillation
Clinical narrative: patient came in today on march 8th, to report she experienced atrial fibrillation, and went into a-fib two days after receiving the vaccine. she states she believes the vaccine caused her to go into a-fib as her heart rate has been consistent since her ablation therapy. she wanted this reported
Age: 0.42
Sex: M
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Flu vaccine was given too early
Age: 10.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received 12+ pfizer vaccine inadvertantly instead of 5-11y pfizer vaccine. Per parent, patient experienced no adverse reactions.
Age: 91.0
Sex: M
Vaccine: MMRV
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Site reaction and the redness passed his knee and warm to the touch. Also got swollen.
Age: 2.0
Sex: F
Vaccine: COVID19, DTPPVHBHPB, FLU4, HEPA, HIBV, MMR, PNC15, VARCEL
Symptoms: Extra dose administered
Clinical narrative: Inadvertently administered additional Hib vaccines in addition to combo Vaxelis.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness, Injected limb mobility decreased, Malaise, Sleep disorder
Clinical narrative: On the evening of the booster shot I started feeling unwell, flu-like symptoms, and my right shoulder was in so much pain I needed pain relievers to try and sleep. For at least 2 weeks it was difficult to sleep due to the pain. Although the pain is not as intense it still affects my sleep and limits the  use of my right arm.
Age: 11.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Incorrect dose administered, Pain, Pain in extremity, Pyrexia
Clinical narrative: Patient received a potential overdose of the covid vaccine. Entire vial was drawn up instead of the 0.25ml dose. Unknown how much was administered. Post vaccine, patient had terrible headache, fever like sx's, achy, sore arm. Fully recovered now.
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condition aggravated, Incorrect dose administered, Sleep disorder
Clinical narrative: Patient may have received incorrect dose as the entire single dose via was administered. It is not known that volume was administered. Parents report difficulty with his sleep routines which started prior to the vaccine error but might be worse since then.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2, COVID19-2
Symptoms: Brain fog, Fatigue, Headache, Magnetic resonance imaging head, Malaise
Clinical narrative: Heart palpitations, Tunnel Vision, Fatigue, Post Exertional Malaise, Sleep Disturbances, Headaches, Brain Fog, Intermittent Tinnitis, Internal Tremors.  I went to Urgent care that night (11/5/22) and the ER the next day (11/6/22).  I then met with my primary care physician, a cardiologist and an endocrynologist over the course of the following weeks.  The symptoms eased over the next two weeks.  I then had all of these symptoms return in April 2023 and have persisted ever since.  I was very recently referred to a nearby long-covid clinic for evaluation.  I am currently pursuing treatment as a result of that consultation.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2, COVID19-2
Symptoms: Palpitations, Sleep disorder, Tinnitus, Tremor, Tunnel vision
Clinical narrative: Heart palpitations, Tunnel Vision, Fatigue, Post Exertional Malaise, Sleep Disturbances, Headaches, Brain Fog, Intermittent Tinnitis, Internal Tremors.  I went to Urgent care that night (11/5/22) and the ER the next day (11/6/22).  I then met with my primary care physician, a cardiologist and an endocrynologist over the course of the following weeks.  The symptoms eased over the next two weeks.  I then had all of these symptoms return in April 2023 and have persisted ever since.  I was very recently referred to a nearby long-covid clinic for evaluation.  I am currently pursuing treatment as a result of that consultation.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2, COVID19-2
Symptoms: Ultrasound scan
Clinical narrative: Heart palpitations, Tunnel Vision, Fatigue, Post Exertional Malaise, Sleep Disturbances, Headaches, Brain Fog, Intermittent Tinnitis, Internal Tremors.  I went to Urgent care that night (11/5/22) and the ER the next day (11/6/22).  I then met with my primary care physician, a cardiologist and an endocrynologist over the course of the following weeks.  The symptoms eased over the next two weeks.  I then had all of these symptoms return in April 2023 and have persisted ever since.  I was very recently referred to a nearby long-covid clinic for evaluation.  I am currently pursuing treatment as a result of that consultation.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: continued aching in left upper arm
Age: 1.25
Sex: F
Vaccine: DTAP
Symptoms: Discomfort, Erythema, Pyrexia
Clinical narrative: Tightness, redness 4x3, fever of 103,
Age: 0.58
Sex: M
Vaccine: HEP, PNC13
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No known adverse side effects. Pt received duplicate Prevnar in error.
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Headache, Injection site swelling, Pain, Pneumonia
Clinical narrative: PATIENT EXPERIENCED CHILLS, ACHES, HEADACHE AND FEVER. HER ARM SWELLING WAS EXTENSIVE FROM THE SITE OF THE INJECTION UP TO THE BACK OF HER EAR.  1 WEEK LATER SHE WAS DIAGNOSED WITH PNEUMONIA
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Pyrexia, Swelling
Clinical narrative: PATIENT EXPERIENCED CHILLS, ACHES, HEADACHE AND FEVER. HER ARM SWELLING WAS EXTENSIVE FROM THE SITE OF THE INJECTION UP TO THE BACK OF HER EAR.  1 WEEK LATER SHE WAS DIAGNOSED WITH PNEUMONIA
Age: 3.0
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Kinrix combination vaccine administered rather than separate Dtap Dose 3 and Polio Dose 4
Age: 8.0
Sex: M
Vaccine: MNQ
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Wrong vaccine given. too young for Men 4. Needed TDAP.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Back pain, Blood test, Computerised tomogram, Dizziness
Clinical narrative: After completing the three vaccines, I've started developing shakiness, stiffness, back pain, dizziness, high blood pressure, and lack of strength in my legs and arms.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Hypertension, Magnetic resonance imaging, Musculoskeletal stiffness, Parkinson's disease
Clinical narrative: After completing the three vaccines, I've started developing shakiness, stiffness, back pain, dizziness, high blood pressure, and lack of strength in my legs and arms.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tremor, Urine analysis, X-ray
Clinical narrative: After completing the three vaccines, I've started developing shakiness, stiffness, back pain, dizziness, high blood pressure, and lack of strength in my legs and arms.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Behaviour disorder, Brain fog, Fatigue
Clinical narrative: Extreme inflammation, fatigue,brain fox, lethargy,behavior issues re adhd symptoms, joint pain and back pain worse than anything experienced before had history of autoimmune and knew the difference
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inflammation, Lethargy
Clinical narrative: Extreme inflammation, fatigue,brain fox, lethargy,behavior issues re adhd symptoms, joint pain and back pain worse than anything experienced before had history of autoimmune and knew the difference
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient expired 3/7/2024.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Abdominal discomfort, Abdominal pain upper, Chills, Dizziness, Erythema
Clinical narrative: About 1.5 hour after receiving the vaccine client became extremely dizzy, developed stomach cramps, vomiting, chills. Arm became red and swollen more than it has with previous vaccines. Client is feeling better today but still has some dizziness and stomach upset.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Peripheral swelling, Vomiting
Clinical narrative: About 1.5 hour after receiving the vaccine client became extremely dizzy, developed stomach cramps, vomiting, chills. Arm became red and swollen more than it has with previous vaccines. Client is feeling better today but still has some dizziness and stomach upset.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Medical Assistant administered Covid 19 vaccine 6 months to less than 5 years dose to an adult patient.  Patient did not develop any adverse reactions from vaccine.  Patient was called by MA to return to clinic to receive correct recommended Covid 19 vaccine for her age.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Seizure, Syncope
Clinical narrative: Syncope and Seizure activity following (convulsing x2 for 10 seconds each)
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Medical Assistant administered Covid 19 vaccine 6 months to less than 5 years dose to an adult patient.  Patient did not develop any adverse reactions from vaccine.  Patient was called by MA to return to clinic to receive correct recommended Covid 19 vaccine for her age.
Age: 7.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Wrong product administered
Clinical narrative: INCIDENTLY GRABED WRONG VACCINE FROM REFRIDGERATOR.
Age: 1.42
Sex: F
Vaccine: VARCEL
Symptoms: No adverse event
Clinical narrative: NONE AT THE MOMENT
Age: 27.0
Sex: M
Vaccine: FLU4
Symptoms: Fatigue, Incorrect dose administered, Injection site pain
Clinical narrative: High dose 0.7 ml vaccine was administered mistakenly in place of 0.5 ml influenza vaccine. Patient reports mild fatigue and localized soreness at injection site the following day.
Sex: U
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: No additional AE/no PQC.; did not receive full dose of VAQTA; This spontaneous report was received from a medical assistant referring to a patient of unknown age or gender. The patient's pertinent medical history, concurrent condition, concomitant medications, and drug reactions or allergies were not reported.  On 07-FEB-2024, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (1 dosage form (1 dose), lot# 1971534, expiration date 06-OCT-2024; strength, route and anatomical location were not reported) for prophylaxis. The operator of the device was a healthcare professional (HCP).   During vaccination, the patient did not receive full dose of hepatitis a vaccine, inactivated (VAQTA) due to movement of the patient's leg (Incorrect dose administered). No additional details were provided. No additional adverse event or product quality complaint (PQC) was reported.
Sex: U
Vaccine: HEP
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: infant received the adolescent dose for both the second and third doses; no adverse event; This spontaneous report was received from a registered nurse, referring to an infant patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On unknown dates, the patient was vaccinated with the adolescent dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) for the second and third doses (strength, anatomical site of vaccination, route of administration, lot number and expiration date were not reported) as prophylaxis (incorrect dose administered). No other adverse event.
Sex: M
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine given on 02-MAY-2001; Vaccine given on 29-AUG-2000; This spontaneous report has been received from lawyer and via Immunization Records from a case in litigation for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (2311USA002295), concerning a currently 23-year-old male patient. Information regarding the patient's concurrent conditions, concomitant therapies or medical history provided were captured in 2311USA002295.  On 24-JUN-2000, the patient was vaccinated with the first dose of hepatitis B Vaccine (Recombinant) (manufacturer unknown) (reported as Hepatitis B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis.  On 29-AUG-2000, he was vaccinated with the second dose of hepatitis B Vaccine (Recombinant) (manufacturer unknown) (reported as Hepatitis B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration).  On 02-MAY-2001, he was vaccinated with the third dose of hepatitis B Vaccine (Recombinant) (manufacturer unknown) (reported as Hepatitis B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration).  This is one of the few reports concerning the same patient.; Sender's Comments:  US-009507513-2403USA000585: US-009507513-2403USA000584: US-009507513-2403USA000583: US-009507513-2403USA000586:
Age: 0.17
Sex: M
Vaccine: HIBV
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: vaccine given on 25-OCT-2001; Vaccine given 26-JAN-2001; This spontaneous report has been received from a Lawyer and via Immunization Records from a case in litigation for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (2311USA002295), concerning a currently 23-year-old male patient. Information regarding the patient's concurrent conditions, concomitant therapies or medical history provided were captured in 2311USA002295.  On 28-SEP-2000, the patient was vaccinated with the first dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as Haemophilus B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis.  On 27-NOV-2000, he was vaccinated with the second dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as Haemophilus B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis.  On 26-JAN-2001, he was vaccinated with the third dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as Haemophilus B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age ).  On 25-OCT-2001, he was vaccinated with the fourth dose of of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as Haemophilus B) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis (extra dose administered).  This is one of the few reports concerning the same patient.; Sender's Comments:  2403USA000585: 2403USA000584: 2403USA000586: 2403USA000582:
Sex: M
Vaccine: PPV
Symptoms: Inappropriate schedule of product administration, Product administered to patient of inappropriate age
Clinical narrative: Vaccine given on 26-JAN-2001; Vaccine given on 27-NOV-2000; This spontaneous report has been received via Immunization Records from a case in litigation for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (2311USA002295), concerning a currently 23-year-old male patient. Information regarding the patient's concurrent conditions, concomitant therapies or medical history provided were captured in 2311USA002295.  On 27-NOV-2000, the patient was vaccinated with the first dose of pneumococcal 23v polysaccharide vaccine (manufacturer unknown) (reported as pneumococcal) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age).  On 26-JAN-2001, he was vaccinated with the second dose of pneumococcal 23v polysaccharide vaccine (manufacturer unknown) (reported as pneumococcal) (formulation, dose, route of administration, vaccination site, lot # and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration).   This is one of the few reports concerning the same patient.; Sender's Comments:  US-009507513-2403USA000585: US-009507513-2403USA000583: US-009507513-2403USA000586: US-009507513-2403USA000582:
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: No symptomatic adverse events were reported.; patient was inadvertently administered ROTATEQ that was involved in a supported below range TE. No symptomatic adverse events were reported. No additional information provided. No additional AE/PQC.    ?    Names of; This spontaneous report as received from a Licensed Vocational Nurse refers to a patient of unknown age. There was no information about the patient's medical history, concurrent conditions or concomitant medication.  On 29-FEB-2024, the patient was vaccinated inadvertently with improperly stored reported as supported below range dose of  rotavirus vaccine, live, oral, pentavalent(ROTATEQ), orally, dose: 2 milliliter,  lot # 1968393,expiration date:  24-MAY-2024  for prophylaxis(product storage error).         The administered dose of the vaccine experienced a temperature -2.2 degrees Celsius  for 1 hour, 3 minutes. There was no adverse effect reported.
Age: 12.0
Sex: U
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: patient received their first dose of GARDASIL 9 at the age of 12 and didn't receive their second dose until the age of 17; No additional AE reported; This spontaneous report was received from a licensed practical nurse referring to an adolescent patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date at the patient's age of 12 years-old, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, at a dose of 0.5 milliliters/series, administered for prophylaxis (lot #, expiry date, anatomical location and route of administration were not provided). The patient did not receive the second dose until the age of 17 years-old (inappropriate schedule of product administration).     No additional adverse events were reported. Lot number is being requested and will be submitted if received.
Age: 1.67
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE reported; VARIVAX was given after possibly experiencing a temperature excursion; This spontaneous report was received from an HBP unspecified reporter referring to a 20-month-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 04-JAN-2024, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, administered for prophylaxis (dose, lot #, expiry date, anatomical location and route of administration were not provided) which was given after possibly experiencing a temperature excursion (product storage error).   No additional adverse events were reported. Lot is being requested and will be submitted if received.
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No side effects or symptoms reported; HCP called and reported MMR II vaccine which expired on 03/01/2024 was inadvertently administered on 03/05/2024.; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 05-MAR-2024, the patient was inadvertently vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) injection, lot #W007181, expiration date: 01-MAR-2024 (expired product administered), administered for prophylaxis (strength, dose, vaccination scheme, and route of administration were not provided). No side adverse events or symptoms reported.
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Vaccination failure
Clinical narrative: Suspected Vaccination failure; Shingles; I was miserable; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and feeling miserable (Verbatim: I was miserable). The outcome of the vaccination failure was unknown and the outcome of the shingles and feeling miserable were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and feeling miserable to be related to Shingrix.     It was unknown if the company considered the vaccination failure, shingles and feeling miserable to be related to Shingrix.   Additional Information: GSK Receipt date: 26-FEB-2024 The patient self-reported this case. This case was reported by patient via (social media) interactive digital media. The patient had shingles all over his/her stomach in the middle of a hot summer as he/she was working in a hot factory 12 hours a day. The Physician had told him/her the long name for it and he/she still did not know what it was till years later. The patent gave that physician. the boot. The physician should had said Shingles, she knew patient did not know what that was. He/She suffered so much for a month he/she was miserable. He/She did get his/her shingles shot and have a very mild case off and on. He/She was great not to go through that misery of the first time around. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Get the vaccine, My man has shingles at present/suspected vaccination failure; My man has shingles at present & it is worse; He is in pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine (unknown arm). On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Get the vaccine, My man has shingles at present/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: My man has shingles at present & it is worse) and pain (Verbatim: He is in pain). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved and the outcome of the pain was not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 28-FEB-2024 The case was received from the patient's wife via (social media) interactive digital media. The patient got the vaccine.  The vax was not pleasant, but worth it.  The patient had shingles at present and it was worse.  They had missed several things and she felt worse about how miserable this had made him. The patient was in pain. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; got the shingles really bad lasted a long time; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: got the shingles really bad lasted a long time). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-Mar-2024 This case was reported by the consumer via interactive digital media. The patient stated his/her sister got the vaccine and got shingles which was really bad and lasted a long time. The reporter stated that it was no thank to read the side effects. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Suspected vaccination failure; I have shingles right now; pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I have shingles right now) and pain (Verbatim: pain). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved and the outcome of the pain was not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-Mar-2024 This case was reported by the patient via interactive digital media. The patient stated that he/she had shingles right now. The patient further stated that he/she had vaccine otherwise the pain would be more severe. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: I got the vaccine, then got shingles / suspected vaccination failure; then got shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine (unknown arm). On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I got the vaccine, then got shingles / suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: then got shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-Mar-2024 This case was reported by the patient's friend via interactive digital media. A friend got it on her waist, the reporter mentioned that there is a vaccine for shingles. She said, "I got the vaccine, then got Shingles.  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Chemotherapy, Herpes zoster, Oral herpes, Vaccination failure
Clinical narrative: I ended up getting a tiny dime size patch of Shingles on my arm/ Suspected vaccination failure; Shingles; It works on cold sores too; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I ended up getting a tiny dime size patch of Shingles on my arm/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and cold sores (Verbatim: It works on cold sores too). The patient was treated with zinc oxide (Desitin). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved and the outcome of the cold sores was not reported.   It was unknown if the reporter considered the vaccination failure, shingles and cold sores to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure, shingles and cold sores to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 01-MAR-2024 This case was reported by a patient via interactive digital media. The patient got the vaccines and got chemotherapy and so the patient ended up getting a tiny dime size patch of Shingles on his/her arm. It did not hurt at all. The patient put extra strength Desitin diaper rash ointment on it, it went right away. If the patient did not had the vaccines, it would had been really bad. It works on cold sores too. It was unknown if the reporter considered the adverse events to be related to chemotherapy. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Pruritus, Vaccination failure
Clinical narrative: Suspected vaccination failure; I have had it twice, last time after the vaccie; pain; itchiness; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I have had it twice, last time after the vaccie), pain (Verbatim: pain) and pruritus (Verbatim: itchiness). The outcome of the vaccination failure was unknown and the outcome of the shingles, pain and pruritus were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pain and pruritus to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pain and pruritus to be related to Shingles vaccine.   Additional Information: RA Receipt Date: 01-Mar-2024 This case was reported by the patient via (Privacy) interactive digital media. The patient stated that he/she had it twice, last time after the vaccine. The reporter stated that it was very bad, felt pain, itchiness all at same. The patient stated that the medicine they prescribed did not help much at all. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure/ right now that has shingles; right now that has shingles and she had both vaccines; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine (unknown arm) and the 1st dose of Shingles vaccine (unknown arm). On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure/ right now that has shingles) (serious criteria GSK medically significant) and shingles (Verbatim: right now that has shingles and she had both vaccines). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: RA Receipt Date: 01-Mar-2024 This case was reported by the reporter via (Privacy) interactive digital media. The reporter knows 184 year old senior citizen right now that has shingles and she had both vaccines.  This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2024AMR028051:Case for first dose
Sex: U
Vaccine: VARZOS
Symptoms: Headache, Muscular weakness, Seizure
Clinical narrative: Convulsions; weakness of leg muscles; headache; This serious case was reported by a consumer via interactive digital media and described the occurrence of convulsion in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced convulsion (Verbatim: Convulsions) (serious criteria hospitalization and GSK medically significant), muscle weakness lower limb (Verbatim: weakness of leg muscles) (serious criteria hospitalization) and headache (Verbatim: headache) (serious criteria hospitalization). The outcome of the convulsion, muscle weakness lower limb and headache were not reported.   It was unknown if the reporter considered the convulsion, muscle weakness lower limb and headache to be related to Shingles vaccine.     It was unknown if the company considered the convulsion, muscle weakness lower limb and headache to be related to Shingles vaccine.   Additional Information: GSK receipt date: 01-MAR-2024 This case was reported the patient via interactive digital media. The patient had a bad reaction to the second shoot and had convulsions weakness of leg muscles was hospitalized then went to rehab then 2 weeks of home care.  First time the patient ever had a problem with a vaccine. It all started with the worst headache, have ever had.  The patient asked to be careful.
Sex: U
Vaccine: DTAPIPV, DTAPIPV, VARCEL
Symptoms: Anaphylactic reaction
Clinical narrative: Anaphylactic reaction; This serious case was reported by a nurse via other manufacturer and described the occurrence of anaphylactic reaction in a 6-year-old patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included DTPa-IPV (DTPa-IPV) for prophylaxis and Varicella zoster vaccine (Varicella vaccine) for prophylaxis.   Concurrent medical conditions included food allergy (had allergies to pork/porcine and beef and food allergies with allergies to gelatin).   On an unknown date, the patient received Kinrix, DTPa-IPV and Varicella vaccine. On an unknown date, an unknown time after receiving Kinrix, DTPa-IPV and Varicella vaccine, the patient experienced anaphylactic reaction (Verbatim: Anaphylactic reaction) (serious criteria GSK medically significant). The outcome of the anaphylactic reaction was unknown.   It was unknown if the reporter considered the anaphylactic reaction to be related to Kinrix, Kinrix Pre-Filled Syringe Device and DTPa-IPV.     It was unknown if the company considered the anaphylactic reaction to be related to Kinrix, Kinrix Pre-Filled Syringe Device and DTPa-IPV.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 01-MAR-2024 This case involves a patient who experienced anaphylaxis reaction while he/she received vaccines Diphtheria, Tetanus, AC pertussis and IPV vaccine, varicella zoster vaccine (varicella vaccine) and Kinrix. The patient's past medical treatment, vaccination and family history were not provided.  Other relevant tests included no lab data. It was not reported if the patient received a corrective treatment. Information on the batch number was requested. It was unknown if the reporter considered the anaphylactic reaction to be related to varicella vaccine.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: still got shingles  / Suspected vaccination failure; still got shingles on my face at age 70; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 70-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: still got shingles  / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: still got shingles on my face at age 70). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 03-Mar-2024 This case was reported by the patient via (social media) interactive digital media. The patient stated that he/she had the disease (unspecified). The patient had the shots twice each and still got shingles on his/her face at age of 70. The patient further stated that he/she was in good health otherwise. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK received date: 03-Mar-2024 This case was reported by a patient via (social media) interactive digital media. Patient got the shot and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: suspected vaccination failure/ got the vaccine and still got shingles; shingles; hurt; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure/ got the vaccine and still got shingles) (serious criteria GSK medically significant and other: serious), shingles (Verbatim: shingles) and pain (Verbatim: hurt). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved and the outcome of the pain was not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 03-MAR-2024 This case was reported by a consumer via (social media) interactive digital media. The patient got the shingles vaccine and still got shingles.  The reporter stated that mine did not come out in a rash, so it took a long time to figure out what it was 2 months and starting on the third month.  They were terrible and hurt so bad. The patient hated to think what they would be if he/she had not got the shot.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Hyperaesthesia, Pain, Vaccination failure
Clinical narrative: Patient got shingles after vaccine shot/Suspected vaccination failure; Hurt; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Patient got shingles after vaccine shot/Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and pain (Verbatim: Hurt). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved (duration 1 week) and the outcome of the pain was resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 02-MAR-2024 This case was reported by a patient via interactive digital media. The patient stated that he/she got the Shingles after getting the shot, it hurt like crazy but only last like a week which was way shorter time than if you did not had shot and if you get them find a very soft throw to lay on and one to cover with cause a sheet about killed you felt like it has stickers in it. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Sex: U
Vaccine: RSV
Symptoms: Unevaluable event
Clinical narrative: Hospitalization; This serious case was reported by a consumer via interactive digital media and described the occurrence of hospitalization in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced hospitalization (Verbatim: Hospitalization) (serious criteria hospitalization). The outcome of the hospitalization was not reported.   It was unknown if the reporter considered the hospitalization to be related to Arexvy.     It was unknown if the company considered the hospitalization to be related to Arexvy.   Additional Information: GSK Receipt Date: 01-MAR-2024 The patient had adverse reaction to this Vaccine and had 21 days hospitalization. Follow-up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Pallor, Stress, Vaccination failure
Clinical narrative: Suspected vaccination failure; Shingles; feeling horrible for 2 days now; Pale; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), feeling abnormal (Verbatim: feeling horrible for 2 days now) and pallor (Verbatim: Pale). The outcome of the vaccination failure was unknown and the outcome of the shingles and pallor were not reported and the outcome of the feeling abnormal was not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, feeling abnormal and pallor to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, feeling abnormal and pallor to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 03-Mar-2024 This case was reported by the patient via interactive digital media. The patient stated that he/she got shingles when he/she was most stressed out in a job. The patient stated this vaccine had made him/her knocked down, feeling horrible for two days now, pales in comparison to shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.